Materiality and Corporate Social Responsibility Reporting for Roche Colombia

Situation

The Roche pharmaceutical company is a pioneer in the area of ​​health. It has an innovative range of products and services for the early detection, prevention, diagnosis and treatment of diseases, and works to improve people’s health and quality of life.

During the first half of 2019 Anthesis were commissioned to support Roche Colombia’s operations develop its integrated Corporate Social Responsibility (CSR) report for the 2018 reporting period.

Roche Colombia wanted to create end-of-life value for all its stakeholders through its powerful model of sustainable value creation. The premise of this model was to create value by contributing more time to making difference through diagnostic solutions, treatments and medical devices, while simultaneously promoting accessibility to its services which would benefit as many people as possible.

Solution

Our communications team supported content generation for the report, working together with the Roche CSR team and their ‘Sustainability Champions’ from different departments in the organisation. A standardised methodology for compiling quantitative and qualitative information was used that allowed us to balance the content according to a previously defined structure.

A materiality analysis was also carried out to strengthen its sustainability strategy. To achieve this, we meticulously reviewed strategic information from the company, its stakeholders and the pharmaceutical sector in order to succinctly define the important aspects of the management process within the organisation.

Impact

As part of a joint effort with the Roche CSR team, an integrated report with engaging infographic elements was used to disseminate its 2018 results among key stakeholders and interest groups.